Clinical Trials
10 trialsNCT07410117 2026-05-27
ROXI-CAT-I
Regeneron Pharmaceuticals
Phase 3 Recruiting
NCT07399977 2026-05-05
Using a Blood Test and Software Tool to Guide Treatment for Venous Thromboembolism
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT05171075 2026-04-17
MAGNOLIA
Anthos Therapeutics, Inc.
Phase 3 Terminated
NCT06886516 2026-04-15
Apixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
Phase EARLY_PHASE1 Recruiting
NCT07493304 2026-03-25
ROXI-CAT-II
Regeneron Pharmaceuticals
Phase 3 Not yet recruiting
NCT07439991 2026-02-27
Study of Risk Factors and Prediction of Blood Clots After Lung Cancer Surgery
The First Hospital of Jilin University
Recruiting
NCT05171049 2026-02-23
ASTER
Anthos Therapeutics, Inc.
Phase 3 Terminated
NCT06861088 2026-02-02
CATIQ P3
Quercis Pharma AG
Phase 3 Recruiting
NCT06672250 2025-09-24
The Correlation Between Circulatory Tumor Cells and Venous Thrombosis
Chang Gung Memorial Hospital
Recruiting
NCT06451003 2025-07-31
Intervention to Improve Utilization of Extended Venous Thromboembolism Prophylaxis After Cancer Surgery
Medical University of South Carolina
Phase NA Recruiting